ASX-Dividend-Report-Banner

Rx-360 Releases Two New Publications in Support of the Pharmaceutical Industry and Patient Safety

November 14, 2023 06:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Rx-360 Releases Two New Publications in Support of the Pharmaceutical Industry and Patient Safety
Image source: Kalkine Media

PHILADELPHIA, Nov. 14, 2023 /PRNewswire/ -- Rx-360 is pleased to announce that the consortium membership led by key members of the Supplier Quality Working Group have released two new papers this week to help drive best practices in pharmaceutical supply chain integrity and patient safety.

The two papers that have been released are "Quality Elements for Suppliers of Products or Services to GMP Regulated Companies" and the "Managing of Critical Vendors (Version 2.0)".  These two papers mark significant milestones in Rx-360's continued evolution as a nonprofit member driven consortium.    

Jim Fries, CEO of Rx-360 commented, "Being able to watch industry peers work together to develop and launch best practice publications is very humbling.  We all know that patient safety is of the utmost importance when it comes to the development and commercialization of pharmaceutical products and these two papers show the commitment of the industry to supply chain integrity."

The two papers focus on topics such as identifying critical vendors, risk evaluation, analyzing data integrity, and ten key principles of GMP.

These two papers can be downloaded from the Rx-360 website (www.rx-360.org) or by contacting the consortium at [email protected]

About Rx-360:

Rx-360, an international nonprofit pharmaceutical supply chain consortium, was formed in 2009 to support an industry-wide commitment to ensuring patient safety by enhancing quality and authenticity throughout the supply chain. The organization's mission is to protect patient safety by sharing information and developing processes related to the integrity of the healthcare supply chain and the quality of materials within the supply chain. To learn more about Rx-360, please visit http://www.Rx-360.org or email [email protected].

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.